219 related articles for article (PubMed ID: 25690487)
1. Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.
Patel B; Hirsch C; Clemente M; Sekeres M; Makishima H; Maciejewski JP
Int J Hematol; 2015 Mar; 101(3):213-8. PubMed ID: 25690487
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
Patel U; Luthra R; Medeiros LJ; Patel KP
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
[TBL] [Abstract][Full Text] [Related]
3. Perspective on how to approach molecular diagnostics in acute myeloid leukemia and myelodysplastic syndromes in the era of next-generation sequencing.
Kohlmann A; Bacher U; Schnittger S; Haferlach T
Leuk Lymphoma; 2014 Aug; 55(8):1725-34. PubMed ID: 24144312
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.
Sakr R; Renneville A; Saada V; Cotteret S; Martin JE; Droin N; Selimoglu-Buet D; Besse B; Hollebecque A; Marzac C; Pasquier F; Micol JB; De Botton S; Mir O; Solary E; Willekens C
Leuk Lymphoma; 2018 Jul; 59(7):1742-1745. PubMed ID: 29115897
[No Abstract] [Full Text] [Related]
5. Molecular Pathology of Myeloid Neoplasms: Molecular Pattern Recognition.
Sadigh S; Kim AS
Clin Lab Med; 2024 Jun; 44(2):339-353. PubMed ID: 38821648
[TBL] [Abstract][Full Text] [Related]
6. Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?
Nazha A; Sekeres MA; Gore SD; Zeidan AM
Oncologist; 2015 Sep; 20(9):1069-76. PubMed ID: 26194858
[TBL] [Abstract][Full Text] [Related]
7. [A novel prognostic model incorporating genetic profiling for myelodysplastic syndromes].
Nagata Y; Ogawa S
Rinsho Ketsueki; 2017; 58(7):776-786. PubMed ID: 28781274
[TBL] [Abstract][Full Text] [Related]
8. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
9. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
Duncavage EJ; Tandon B
Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
[TBL] [Abstract][Full Text] [Related]
10. Molecular findings in myeloid neoplasms.
Tran TB; Siddon AJ
Int J Lab Hematol; 2023 Aug; 45(4):442-448. PubMed ID: 37345257
[TBL] [Abstract][Full Text] [Related]
11. Founder and subclonal mutations in myelodysplastic syndromes and related myeloid neoplasms.
Makishima H
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101189. PubMed ID: 33038978
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.
Vantyghem S; Peterlin P; Thépot S; Ménard A; Dubruille V; Debord C; Guillaume T; Garnier A; Le Bourgeois A; Wuilleme S; Godon C; Theisen O; Eveillard M; Delaunay J; Maisonneuve H; Morineau N; Villemagne B; Vigouroux S; Subiger F; Lestang E; Loirat M; Parcelier A; Godmer P; Mercier M; Trebouet A; Luque Paz D; Le Calloch R; Le Clech L; Bossard C; Moreau A; Ugo V; Hunault M; Moreau P; Le Gouill S; Chevallier P; Béné MC; Le Bris Y
Haematologica; 2021 Mar; 106(3):701-707. PubMed ID: 32241844
[TBL] [Abstract][Full Text] [Related]
13. Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms.
Kanagal-Shamanna R; Hodge JC; Tucker T; Shetty S; Yenamandra A; Dixon-McIver A; Bryke C; Huxley E; Lennon PA; Raca G; Xu X; Jeffries S; Quintero-Rivera F; Greipp PT; Slovak ML; Iqbal MA; Fang M
Cancer Genet; 2018 Dec; 228-229():197-217. PubMed ID: 30377088
[TBL] [Abstract][Full Text] [Related]
14. Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.
Bacher U; Shumilov E; Flach J; Porret N; Joncourt R; Wiedemann G; Fiedler M; Novak U; Amstutz U; Pabst T
Blood Cancer J; 2018 Nov; 8(11):113. PubMed ID: 30420667
[TBL] [Abstract][Full Text] [Related]
15. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
[TBL] [Abstract][Full Text] [Related]
16. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.
Ok CY; Patel KP; Garcia-Manero G; Routbort MJ; Fu B; Tang G; Goswami M; Singh R; Kanagal-Shamanna R; Pierce SA; Young KH; Kantarjian HM; Medeiros LJ; Luthra R; Wang SA
Leuk Res; 2015 Mar; 39(3):348-54. PubMed ID: 25573287
[TBL] [Abstract][Full Text] [Related]
17. Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome Patients.
Palomo L; Fuster-Tormo F; Alvira D; Ademà V; Armengol MP; Gómez-Marzo P; de Haro N; Mallo M; Xicoy B; Zamora L; Solé F
Biopreserv Biobank; 2017 Aug; 15(4):360-365. PubMed ID: 28586236
[TBL] [Abstract][Full Text] [Related]
18. [Sequential acquisition of mutations in myelodysplastic syndromes].
Makishima H
Rinsho Ketsueki; 2017; 58(10):1828-1837. PubMed ID: 28978821
[TBL] [Abstract][Full Text] [Related]
19. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
20. Mutational profiling in patients with MDS: ready for every-day use in the clinic?
Bacher U; Kohlmann A; Haferlach T
Best Pract Res Clin Haematol; 2015 Mar; 28(1):32-42. PubMed ID: 25659728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
